Literature DB >> 31587302

European and American WAIS IV norms: Cross-national differences in perceptual reasoning, processing speed and working memory subtest scores.

Eka Roivainen1.   

Abstract

International comparisons of IQ test norms show differences between nations. In the present study, nonverbal reasoning, processing speed and working memory subtest scores of the US, German, French, Finnish, and Scandinavian (combined Swedish-Norwegian-Danish sample) WAIS IV standardization samples were compared. The European samples had higher scores on the reasoning subtests compared to the American sample, corroborating earlier studies. The Finnish and Scandinavian samples had lower processing speed and working memory scores than the American, German, and French samples. Mechanisms that may underlie the observed national IQ profiles include: (1) test-taking attitudes-in tests that require balancing speed and accuracy of performance Americans may prioritize fast performance while Europeans avoid mistakes; (2) differences between languages in digit articulation times; and (3) educational factors-the European advantage on reasoning subtests may be based on there being better educational systems in Europe as compared to the US.
© 2019 Scandinavian Psychological Associations and John Wiley & Sons Ltd.

Keywords:  Intelligence ; WAIS IV ; cross-national; test norms

Mesh:

Year:  2019        PMID: 31587302     DOI: 10.1111/sjop.12581

Source DB:  PubMed          Journal:  Scand J Psychol        ISSN: 0036-5564


  2 in total

1.  An examination of factors that may contribute to gender differences in psychomotor processing speed.

Authors:  Eka Roivainen; Frans Suokas; Anne Saari
Journal:  BMC Psychol       Date:  2021-12-02

2.  Anxiety severity and cognitive function in primary care patients with anxiety disorder: a cross-sectional study.

Authors:  Jenny Nyberg; Malin Henriksson; Alexander Wall; Torbjörn Vestberg; Maria Westerlund; Marion Walser; Robert Eggertsen; Louise Danielsson; H Georg Kuhn; N David Åberg; Margda Waern; Maria Åberg
Journal:  BMC Psychiatry       Date:  2021-12-09       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.